We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
In vitro effects of anti-MRSA agent adsorption onto the AN69ST hemofilter.
- Authors
Inano, Yoshinori; Tsuchiya, Kayoko; Kumano, Ryota; Miura, Go; Nakasa, Hiromitsu
- Abstract
Background: Blood purification therapy with a sulfonated polyacrylonitrile surface treated (AN69ST) hemofilter is used to treat sepsis. However, the AN69ST hemofilter has been reported to adsorb and remove therapeutic drugs; warranting further investigation. In this study, we evaluated the adsorption effects of AN69ST membranes and hemofilters connected to a dialysis circuit model on anti-methicillin-resistant Staphylococcus aureus (anti-MRSA) agents, such as arbekacin sulfate (ABK), linezolid (LZD), vancomycin hydrochloride (VCM), teicoplanin (TEIC), and daptomycin (DAP), in in vitro experiments. Methods: Drug solutions were exposed to AN69ST membranes. The absorbance of the drug solution was measured over time, and the drug content was calculated. Additionally, we calculated the drug content over time by circulating the drug solution through a dialysis circuit model. The clearance of each drug was determined at 5 and 60 min. Results: The content of ABK, TEIC, DAP, and VCM decreased substantially after the addition of AN69ST membranes compared to those of the standard reagent. However, the LZD content did not decrease. In the dialysis circuit model, the content of ABK, TEIC, DAP, and VCM were 3.7%, 25.7%, 43.8%, and 44.5%, respectively, at 20 min, which were clearly lower than those of the standard reagent (62–64%). However, the LZD content remained unchanged. The clearance of ABK, TEIC, DAP, and VCM increased after 5 min. Conclusions: The in vitro adsorption of anti-MRSA agents onto the AN69ST hemofilter was confirmed for ABK, TEIC, DAP, and VCM. Positively charged ABK was particularly susceptible to adsorption and should be avoided during blood purification using the AN69ST hemofilter. In addition, we concluded that TEIC, DAP, and VCM should be used for therapeutic drug monitoring because the adsorption rate of each drug is believed to vary depending on its protein binding rate.
- Subjects
ARTIFICIAL membranes; DRUG efficacy; IN vitro studies; METHICILLIN-resistant staphylococcus aureus; VANCOMYCIN; LINEZOLID; ADSORPTION (Chemistry); PEPTIDE antibiotics; RESEARCH funding; DRUG monitoring; DESCRIPTIVE statistics; HEMODIALYSIS; DAPTOMYCIN; MOLECULAR structure; DATA analysis software; ANTIBIOTICS; BLOOD filtration; SPECTROPHOTOMETRY; PHARMACODYNAMICS
- Publication
Renal Replacement Therapy, 2024, Vol 10, Issue 1, p1
- ISSN
2059-1381
- Publication type
Article
- DOI
10.1186/s41100-024-00527-1